Stem cell studies of congestive heart failure in dogs could benefit humans, too – Medical Xpress
Medical Xpress |
Stem cell studies of congestive heart failure in dogs could benefit humans, too
Medical Xpress Injecting stem cells into a dog’s bloodstream should allow them to travel to the heart, where they theoretically could promote regeneration of damaged valves. However, scientists still do not understand the full potential of stem cells to treat heart … |
Fred Hutch News Service |
A Q&A with immunotherapy researcher Dr. Rachel Perret
Fred Hutch News Service Fred Hutchinson Cancer Research Center’s Dr. Rachel Perret is one of those lucky few. A postdoctoral research fellow training under the mentorship of immunotherapy expert Dr. Phil Greenberg, Perret spends her days — and sometimes her nights — working … |
Bloomberg |
Juno Therapeutics CEO Bishop on Immunotherapy
Bloomberg Juno Therapeutics CEO Hans Bishop discusses the company’s immunotherapy for cancer. He speaks with Erik Schatzker on “Bloomberg Technology” from the JPMorgan Healthcare Conference. (Source: Bloomberg) … |
Fortune |
Monsanto’s New Biotech Tools Must Avoid the Same Public Relations Fate as GMOs
Fortune With tools like CRISPR, plant scientists would be able to focus on developing traits other than the pest resistance and herbicide tolerance that dominate the GMO market—something such as enhanced nutrition that might be more palatable to consumers. |
Gizmodo |
Why the Patent Battle Over CRISPR Matters (and Why It Doesn’t)
Gizmodo By the time a panel of judges at the U.S. Patent and Trademark Office gets around to deciding who owns the biggest biotechnology innovation of the century, CRISPR-Cas9 may have already lost its heavyweight title as the most precise tool for genetic … How Gene Editing Could Ruin Human EvolutionTIME Interference: A CRISPR Patent Dispute Roadmap – Bio-IT WorldBio-IT World The Patent Fight Over CRISPR Hinges on a Microscopic DetailPopular Mechanics Next Big Future all 13 news articles » |
|
Researchers Awarded $2.2M for Duchenne Gene Therapy Investigation
Muscular Dystrophy News Mendell is a professor of pediatrics and neurology and director of the center for gene therapy at Nationwide Children’s Hospital’s Research Institute, and Rodino-Klapac heads the Rodino-Klapac Gene Therapy Lab for Muscular Dystrophies, which is focused … |